Eviva Partners Launches the #MAHAKILLS Campaign to Highlight The Adverse Impact of MAHA Policies on Health Outcomes"

Written By Alex Morozov

This is a difficult and unprecedented time in US Healthcare with massive layoffs in the government sector, uncertainty and gag orders, and the rise of the MAHA (Make America Healthy Again) movement. We believe that we are witnessing a revolt against science, medicine and the media that goes well beyond vaccines, and will have an impact for generations to come in the US and around the world. 

This is evident in the supporters surrounding Robert F. Kennedy Jr (figure above),  the February 13 MAHA Alliance press conference led by its CEO, Del Bigtree (see links to podcast/transcript below), and the launch of Trump’s MAHA Commission.  

The Commission will 

  • “Study the scope of the childhood chronic disease crisis and any potential contributing causes, including… medical treatments,… Government policies… electromagnetic radiation… corporate influence and cronyism. 

  • Assess the threat that potential over-utilization of medication…

  • Restore the integrity of science, including by eliminating undue industry influence… and increasing methodological rigor

  • Address appropriately restructuring the Federal Government’s response to the childhood chronic disease crisis, including by ending Federal practices that exacerbate the health crisis…” 

There are only three physicians on the commission. David Weldon is a known anti-vaxxer. Neither Jay Bhattacharia nor Marty Makary have any basic science or clinical trial experience. Both are critics of COVID lockdowns and the medical establishment overall, and are editors of a newly formed Journal of the Academy of Public Health along with others who regard  “Traditional journals as more or less dead.” So they are unlikely to seek expert help beyond loyal figureheads. 

Alex Morozov

Alex Morozov is a physician, scientist and drug developer with a passion for improving health outcomes and reducing care gaps in every community around the world. He is the CEO and founder of Eviva Partners, a nonprofit promoting better understanding of evidence through education and behavioral science approaches for both patients and providers, while characterizing and monitoring improvement in care gaps (defined as both underuse and overuse).  

Alex obtained his undergraduate degree from MIT, followed by combined MD-PhD training at the Albert Einstein College of Medicine in New York. After internal medicine residency at Columbia-Presbyterian and medical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York, Alex was recruited by a friend to join the pharmaceutical industry. Over his 14-year drug development career, Alex has designed, conducted and overseen hundreds of clinical trials, leading to regulatory approval of several new cancer therapies by the FDA and other health authorities around the world. Following his interest in data and digital innovation, he led teams developing and implementing new technologies to accelerate clinical trials, address health equity, and improve outcomes for patients in clinical practice.

He is working on a book called “The Language of Evidence: Getting Well in a World Without Proof,” from which portions of this essay are adopted.

Previous

Can MAHA Spell the End of the Conservative Movement?
Next

Eviva Partners is quoted by POLITICO